Browsing by Subject
Mostrando ítems 1-20 de 115
-
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer
(American Association for Cancer Research, 2024-01-15) -
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
(American Association for Cancer Research, 2023-01-17) -
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
(American Association for Cancer Research, 2024-02-15) -
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer
(Oxford University Press, 2023-03) -
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
(Wolters Kluwer Health, 2021-08) -
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
(American Society of Clinical Oncology, 2023-04-10) -
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors
(Elsevier, 2021-02) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
(American Association for Cancer Research, 2023-06-15)